Cytek Biosciences Inc.

NASDAQ: CTKB · Real-Time Price · USD
4.03
-0.05 (-1.23%)
At close: Aug 15, 2025, 1:23 PM

Cytek Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
200.45M 193.01M 164.04M 127.95M
Cost of Revenue
89.35M 83.59M 63.06M 48.81M
Gross Profit
111.11M 109.43M 100.97M 79.14M
Operating Income
-20.52M -27.84M -1.83M 6.45M
Interest Income
10.36M 6.41M 4.62M 49K
Pretax Income
-5.7M -15.71M 1.26M 5.95M
Net Income
-6.02M -12.15M 2.58M 4.42M
Selling & General & Admin
92.23M 91.62M 67.92M 45.53M
Research & Development
39.4M 44.15M 34.86M 24.44M
Other Expenses
n/a n/a 1.02M n/a
Operating Expenses
131.63M 137.27M 102.78M 69.98M
Interest Expense
n/a 2.07M 2.57M 1.74M
Selling & Marketing Expenses
49.11M 49.15M 33.23M 24.71M
Cost & Expenses
220.98M 220.86M 165.84M 118.78M
Income Tax Expense
320K -3.56M -1.22M 1.5M
Shares Outstanding (Basic)
130.61M 135.28M 134.51M 133.75M
Shares Outstanding (Diluted)
130.61M 135.28M 138.56M 133.75M
EPS (Basic)
-0.05 -0.09 0.02 0.03
EPS (Diluted)
-0.05 -0.09 0.02 0.03
EBITDA
-10.03M -4.41M 9.54M 10.4M
EBIT
-20.52M -13.64M 3.83M 9.16M
Depreciation & Amortization
10.49M 9.23M 5.7M 1.24M